Kaiming Li

机构：Zhejiang Chinese Medical University, Nanjing General Hospital of Nanjing Military Command, Nanjing University · ORCID：0000-0003-2441-274X

发表论文 21 篇 · 总被引 531 次 · h-index 9

代表论文

• Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy (2020 · Science Translational Medicine · 被引 180)
• Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum (1988 · Journal of Natural Products · 被引 107)
• Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals (2023 · ACS Nano · 被引 76)
• A neutrophil-mimetic magnetic nanoprobe for molecular magnetic resonance imaging of stroke-induced neuroinflammation (2021 · Biomaterials Science · 被引 38)
• Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy (2022 · Acta Pharmaceutica Sinica B · 被引 27)
• Simultaneous blockage of contextual TGF-β by cyto-pharmaceuticals to suppress breast cancer metastasis (2021 · Journal of Controlled Release · 被引 26)